Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Atopic Dermatitis Drugs Market, by Region, 2019-2029 (USD Billion)
1.2.2. Atopic Dermatitis Drugs Market, by Class, 2019-2029 (USD Billion)
1.2.3. Atopic Dermatitis Drugs Market, by Route of Administration, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Atopic Dermatitis Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Atopic Dermatitis Drugs Market Dynamics
3.1. Atopic Dermatitis Drugs Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Robust product portfolio
3.1.1.2. Increasing incidences of atopic dermatitis
3.1.2. Market Challenges
3.1.2.1. High cost of therapeutics
3.1.2.2. Some side-effects associated with drugs
3.1.3. Market Opportunities
3.1.3.1. Increasing product approvals
3.1.3.2. Growing R&D investments by the key market players
Chapter 4. Global Atopic Dermatitis Drugs Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Atopic Dermatitis Drugs Market, by Class
6.1. Market Snapshot
6.2. Global Atopic Dermatitis Drugs Market by Class, Performance - Potential Analysis
6.3. Global Atopic Dermatitis Drugs Market Estimates & Forecasts by Class 2019-2029 (USD Billion)
6.4. Atopic Dermatitis Drugs Market, Sub Segment Analysis
6.4.1. Corticosteroids
6.4.2. Calcineurin Inhibitors
6.4.3. PDE4 Inhibitors
6.4.4. Biologics
6.4.5. Others
Chapter 7. Global Atopic Dermatitis Drugs Market, by Route of Administration
7.1. Market Snapshot
7.2. Global Atopic Dermatitis Drugs Market by Route of Administration, Performance - Potential Analysis
7.3. Global Atopic Dermatitis Drugs Market Estimates & Forecasts by Route of Administration 2019-2029 (USD Billion)
7.4. Atopic Dermatitis Drugs Market, Sub Segment Analysis
7.4.1. Topical
7.4.2. Injectable
7.4.3. Oral
Chapter 8. Global Atopic Dermatitis Drugs Market, Regional Analysis
8.1. Atopic Dermatitis Drugs Market, Regional Market Snapshot
8.2. North America Atopic Dermatitis Drugs Market
8.2.1. U.S. Atopic Dermatitis Drugs Market
8.2.1.1. Class breakdown estimates & forecasts, 2019-2029
8.2.1.2. Route of Administration breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Atopic Dermatitis Drugs Market
8.3. Europe Atopic Dermatitis Drugs Market Snapshot
8.3.1. U.K. Atopic Dermatitis Drugs Market
8.3.2. Germany Atopic Dermatitis Drugs Market
8.3.3. France Atopic Dermatitis Drugs Market
8.3.4. Spain Atopic Dermatitis Drugs Market
8.3.5. Italy Atopic Dermatitis Drugs Market
8.3.6. Rest of Europe Atopic Dermatitis Drugs Market
8.4. Asia-Pacific Atopic Dermatitis Drugs Market Snapshot
8.4.1. China Atopic Dermatitis Drugs Market
8.4.2. India Atopic Dermatitis Drugs Market
8.4.3. Japan Atopic Dermatitis Drugs Market
8.4.4. Australia Atopic Dermatitis Drugs Market
8.4.5. South Korea Atopic Dermatitis Drugs Market
8.4.6. Rest of Asia Pacific Atopic Dermatitis Drugs Market
8.5. Latin America Atopic Dermatitis Drugs Market Snapshot
8.5.1. Brazil Atopic Dermatitis Drugs Market
8.5.2. Mexico Atopic Dermatitis Drugs Market
8.5.3. Rest of Latin America Atopic Dermatitis Drugs Market
8.6. Rest of The World Atopic Dermatitis Drugs Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Pfizer Inc.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Sanofi
9.2.3. AbbVie Inc.
9.2.4. GALDERMA LABORATORIES, L.P.
9.2.5. Eli Lilly and Company (Dermira)
9.2.6. Regeneron Pharmaceuticals Inc.
9.2.7. LEO Pharma Inc.
9.2.8. Otsuka Pharmaceutical Co., Ltd.
9.2.9. Novartis AG
9.2.10. Incyte Corporation
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption